Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 28 jun 2018 - 22:35
- Statutory name Galapagos N.V.
- Title Topline results of PELICAN trial and update on triple combo development plans
|201806280000000013_Eerste trial met C2 corrector GLPG2737 in CF.pdf|
|201806280000000013_First trial to evaluate C2 corrector GLPG2737 in CF patients treated with Orkambi.pdf|
Date last update: 21 November 2018